(Q34303186)

English

Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

adrenal insufficiency

1 reference

based on heuristic

inferred from title

author name string

M Forss

1

1 reference

Europe PubMed Central

1 August 2017

G Batcheller

2

1 reference

Europe PubMed Central

1 August 2017

S Skrtic

3

1 reference

Europe PubMed Central

1 August 2017

G Johannsson

4

1 reference

Europe PubMed Central

1 August 2017

publication date

13 June 2012

1 reference

Europe PubMed Central

1 August 2017

BMC Endocrine Disorders

1 reference

Europe PubMed Central

1 August 2017

12

1 reference

Europe PubMed Central

1 August 2017

8

1 reference

Europe PubMed Central

1 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

13 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1472-6823-12-8

0 references

Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Modified-release hydrocortisone to provide circadian cortisol profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3403959

6 July 2018

Premature mortality in patients with Addison's disease: a population-based study

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Subjective health status in Norwegian patients with Addison's disease

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Continuous subcutaneous hydrocortisone infusion in Addison's disease.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Assessing the HPA axis in patients with pituitary disease: a UK survey

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Development of a disease-specific quality of life questionnaire in Addison's disease.

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-12-8

21 January 2018

Bone mineral density is reduced in female but not male subjects with Addison's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroid replacement therapy: twice or thrice daily?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22695167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1472-6823-12-8

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34303186&oldid=1800697827"